METHOD OF EVALUATING TOXIC EFFECTS OF SILVER NANOPARTICLES ENCAPSULATED WITHIN POLYMER MATRIX OF ARABINOGALACTAN ON BRAIN TISSUE OF LABORATORY ANIMALS IN LONG-TERM Russian patent published in 2016 - IPC G09B23/28 B82B1/00 

Abstract RU 2578545 C1

FIELD: medicine.

SUBSTANCE: invention relates to experimental medicine, general toxicology and nanotoxicology, and concerns criteria for diagnosis of toxic action of silver nanoparticles encapsulated in a natural polymer matrix of arabinogalactan (AG) on brain tissue of rats in long term. Method comprises exposing animal test group to toxicant by intragastric administration of an aqueous solution of AG with silver nanoparticles (nano-Ag-AG) in amount of 100 mcg per kilogram of silver in 0.5 ml of distilled water for 9 days. Control animals a subjected to intragastric administration of 0.5 ml of distilled water and for 9 days. After 6 months sectioning of cortex tissue from both groups of animals is performed. Stained with antibody to protein caspase-3, and survey microscopy of obtained preparations is performed. Number of pathologically altered neurons without expression of caspase 3, number of pathologically altered neurons expressing caspase 3, number of normal neurons without expression of caspase 3, number of normal neurons expressing caspase 3, total number of neurons per unit cut area is determined. Ratio of said indicators on preparations of experimental group to that of control group on preparations is calculated. By increasing number of pathologically altered neurons without expression of caspase 3 by 1.6 times relative to control group, increase in number of pathologically altered neurons expressing caspase 3 by 2.7 times relative to control group, reducing number of normal neurons without caspase 3 0.6 times in relation to control group, increase in number of normal neurons expressing caspase 3 2-fold relative to control group as well as reducing total number of neurons per unit area of 0.5 times relative to control group of development of inferring pathological process predominant damage type apoptosis in brain tissue in long term effects of nano-Ag-AG.

EFFECT: method improves accuracy of verification toxic encephalopathies, including due to registration of functional changes of morphometric characteristics of neurons.

1 cl, 1 tbl, 1 ex

Similar patents RU2578545C1

Title Year Author Number
METHOD OF ESTIMATION OF THE APOPTOSIS PROCESS IN THE FABRIC OF THE BRAIN OF LABORATORY ANIMALS 2016
  • Titov Evgenij Alekseevich
  • Novikov Mikhail Aleksandrovich
  • Sosedova Larisa Mikhajlovna
  • Ganenko Tatyana Vasilevna
  • Sukhov Boris Gennadevich
  • Trofimov Boris Aleksandrovich
RU2621122C1
METHOD OF ASSESSING THE TOXIC EFFECT OF A BIMETALLIC FERRUM-GADOLINIUM NANOCOMPOSITE ENCAPSULATED IN A NATURAL POLYMER MATRIX OF ARABINOGALACTAN ON LABORATORY ANIMALS 2019
  • Titov Evgenij Alekseevich
  • Novikov Mikhail Aleksandrovich
  • Sosedova Larisa Mikhajlovna
RU2733504C1
METHOD FOR ESTIMATING THE TOXICITY OF MICRO- AND NANOPARTICLES BY THE MORPHOLOGICAL FEATURES THEREOF 2020
  • Zajtseva Nina Vladimirovna
  • Zemlyanova Marina Aleksandrovna
  • Stepankov Mark Sergeevich
  • Ignatova Anna Mikhajlovna
  • Ignatov Mikhail Nikolaevich
RU2756524C1
DIAGNOSTIC TECHNIQUE FOR MERCURY ENCEPHALOPATHY IN SMALL LABORATORY ANIMALS 2011
  • Titov Evgenij Alekseevich
  • Sosedova Larisa Mikhajlovna
RU2471247C1
METHOD FOR ASSESSING COPPER NANOPARTICLES ADMINISTRATION SAFETY 2011
  • Sizova Elena Anatol'Evna
  • Miroshnikov Sergej Aleksandrovich
  • Poljakova Valentina Sergeevna
  • Glushchenko Natal'Ja Nikolaevna
RU2477485C2
APPLICATION OF (2-IMIDAZOLIN-2-YLAMINO) QUINOXALINES IN DEMENTIA AND PARKINSON'S DISEASE TREATMENT 2003
  • Tatton Vil'Jam G.
  • Viler Larri A.
  • Dzhil Dehniehl V.
  • Donello Dzhon E.
RU2332218C2
MEDICATION FOR TREATMENT OF CARDIOVASCULAR DISEASES 2014
  • Erimbetov Kenes Tagaevich
  • Podgorodnichenko Vladimir Konstantinovich
  • Khomichenok Viktor Vladimirovich
  • Goncharova Anna Yakovlevna
  • Roziev Rakhimdzhan Akhmetdzhanovich
  • Klejmenov Aleksej Viktorovich
RU2555335C9
GENE-CELL VESICULAR THERAPEUTIC DRUG AND METHOD FOR MULTIPLE SCLEROSIS THERAPY BY TRANSPLANTATION OF A GENE-CELL VESICULAR THERAPEUTIC DRUG 2021
  • Arkhipova Svetlana Sergeevna
  • Alatrash Rim
  • Garanina Ekaterina Evgenevna
  • Rizvanov Albert Anatolevich
RU2762855C1
MEANS OF CHRONIC VENOUS INSUFFICIENCY TREATMENT 2022
  • Kovalskaya Galina Nikolaevna
  • Kolmakova Elena Stepanovna
  • Babkin Vasilij Anatolevich
RU2797950C1
METHOD OF DETECTING PRESENCE OF SYSTEMIC REACTION OF CONNECTIVE TISSUE, CONDITIONED BY DEVELOPMENT OF SYNDROME OF COMBINED DYSTROPHIC-DEGENERATIVE CHANGES OF MESENCHYMAL DERIVATIVES IN CASE OF LOCAL CHRONIC INFLAMMATORY PROCESS 2012
  • Zhurakovskij Igor' Pavlovich
  • Arkhipov Sergej Alekseevich
  • Bitkhaeva Marija Vjacheslavovna
  • Pustovetova Marija Gennad'Evna
  • Marinkin Igor' Olegovich
RU2493777C1

RU 2 578 545 C1

Authors

Titov Evgenij Alekseevich

Novikov Mikhail Aleksandrovich

Sosedova Larisa Mikhajlovna

Dates

2016-03-27Published

2015-01-12Filed